WHO ICTRP trial
A randomised controlled parallel group open-label study to evaluate the efficacy…
EUCTR2009-015766-56-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-015766-56-FR |
|---|---|
| Public title | A randomised controlled parallel group open-label study to evaluate the efficacy and safety of intravenous ferric carboxymaltose versus no treatment in anaemic subjects with multiple myeloma and iron-restricted erythropoiesis receiving chemotherapy |
| Scientific title | A randomised controlled parallel group open-label study to evaluate the efficacy and safety of intravenous ferric carboxymaltose versus no treatment in anaemic subjects with multiple myeloma and iron-restricted erythropoiesis receiving chemotherapy |
| Primary sponsor | Vifor Pharma Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;Greece;Germany |
| Conditions | Treatment of anaemic subjects with multiple myeloma and iron restricted erythropoiesis receiving chemotherapy. MedDRA version: 12.0 Level: LLT Classification code 10028228 Term: Multiple myeloma MedDRA version: 12.0 Level: LLT… |
| Interventions | Trade Name: Ferinject® Pharmaceutical Form: Intravenous infusion INN or Proposed INN: Ferric carboxymaltose (FCM) Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 50- |
| Registration date | Oct 27, 2009 |
| Target size | 40 |
| Secondary IDs | FER-AOC-MM |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: